Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.63 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.60 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.60 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.58 |
| ▸ | PPARG | P37231 | 7/20 | 0.58 |
| ▸ | PPARD | Q03181 | 7/20 | 0.58 |
| ▸ | PPARA | Q07869 | 7/20 | 0.58 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.58 |
| ▸ | TSHR | P16473 | 4/20 | 0.58 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.58 |
| ▸ | TLR2 | O60603 | 2/20 | 0.58 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.58 |
| ▸ | FABP4 | P15090 | 2/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.58 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.58 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.58 |
| ▸ | MEN1 | O00255 | 1/20 | 0.58 |
| ▸ | ESR1 | P03372 | 1/20 | 0.58 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.58 |
| ▸ | PDE4A | P27815 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2990102 | 1.00 | ALDH1A1 (0.63) | ALDH1A1FFAR4FFAR1GPR84PPARG | |
| SCHEMBL951746 | 1.00 | ALDH1A1 (0.63) | ALDH1A1FFAR4FFAR1GPR84PPARG | |
| SCHEMBL16116689 | 1.00 | ALDH1A1 (0.63) | ALDH1A1FFAR4FFAR1GPR84PPARG | |
| SCHEMBL1457100 | 1.00 | ALDH1A1 (0.63) | ALDH1A1FFAR4FFAR1GPR84PPARG | |
| SCHEMBL3003957 | 1.00 | ALDH1A1 (0.63) | ALDH1A1FFAR4FFAR1GPR84PPARG | |
| SCHEMBL2801996 | 1.00 | ALDH1A1 (0.63) | ALDH1A1FFAR4FFAR1GPR84PPARG | |
| SCHEMBL10620340 | 1.00 | ALDH1A1 (0.63) | ALDH1A1FFAR4FFAR1GPR84PPARG | |
| SCHEMBL3002858 | 1.00 | ALDH1A1 (0.63) | ALDH1A1FFAR4FFAR1GPR84PPARG | |
| SCHEMBL5879050 | 1.00 | ALDH1A1 (0.63) | ALDH1A1FFAR4FFAR1GPR84PPARG | |
| Ethane SCHEMBL27529456 | 0.98 | ALDH1A1 (0.61) | ALDH1A1FFAR4FFAR1GPR84PPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4657069-A1 | APPLICATION OF BIOMARKER IN PREPARING METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE CLASSIFICATION PRODUCTS | The First Affiliated Hospital of the Chinese People's Liberation Army Army Medical University (CN) | 2025-12-03 | — | — | EP | claimed |
| US-20260091067-A1 | METHODS AND USES OF MICROBIOME COMPOSITIONS, COMPONENTS, OR METABOLITES FOR TREATING INSULIN-ASSOCIATED DISEASES | MARVELBIOME INC (US) | 2026-04-02 | — | — | US | disclosed |
| US-20250369986-A1 | APPLICATION OF BIOMARKER IN PREPARING METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE CLASSIFICATION PRODUCTS | The First Affiliated Hospital of the Chinese People's Liberation Army Army Medical University (CN) | 2025-12-04 | — | — | US | disclosed |
| EP-4657069-A1 | APPLICATION OF BIOMARKER IN PREPARING METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE CLASSIFICATION PRODUCTS | The First Affiliated Hospital of the Chinese People's Liberation Army Army Medical University (CN) | 2025-12-03 | — | — | EP | disclosed |
| EP-4587116-A2 | METHODS AND USES OF MICROBIOME COMPOSITIONS, COMPONENTS, OR METABOLITES FOR TREATING INSULIN-ASSOCIATED DISEASES | MarvelBiome, Inc. (US) | 2025-07-23 | — | — | EP | disclosed |
| CN-120053661-A | Hydrophilic fatty acid complex for preventing, preventing or treating microbial infection, preparation and application thereof | 太阳雨林(北京)生物医药有限公司 | 2025-05-30 | — | — | CN | disclosed |
| CN-120053660-A | Hydrophilic complex for preventing, preventing or treating microbial infection, preparation and application thereof | 太阳雨林(北京)生物医药有限公司 | 2025-05-30 | — | — | CN | disclosed |
| CN-119855607-A | Carbon chain substance for regulating transmembrane transport and fluidity of cell membrane, preparation and application | 太阳雨林(北京)生物医药有限公司 | 2025-04-18 | — | — | CN | disclosed |
| WO-2025054048-A1 | METHODS AND USES OF MICROBIOME COMPOSITIONS, COMPONENTS, OR METABOLITES FOR TREATING LIPID AND CHOLESTEROL METABOLISM ASSOCIATED DISEASES, DISORDERS, AND CONDITIONS | MarvelBiome, Inc. (US) | 2025-03-13 | — | — | WO | disclosed |
| EP-4520348-A1 | CARBON CHAIN SUBSTANCE FOR REGULATING TRANSMEMBRANE TRANSPORT AND FLUIDITY OF CELL MEMBRANES, AND PREPARATION AND USE THEREOF | Sunforest (Beijing) Biopharma Ltd (CN) | 2025-03-12 | — | — | EP | disclosed |
| US-20040092418-A1 | Fatty acids, soaps surfactant systems, and consumer products based thereon | CONNOR DANIEL STEDMAN (US) | 2004-05-13 | — | — | US | disclosed |
| US-20040092419-A1 | Fatty acids, soaps, surfactant systems, and consumer products based thereon | THE PROCTER & GAMBLE COMPANY | 2004-05-13 | — | — | US | disclosed |
| US-20040087461-A1 | Fatty acids, soaps, surfactant systems, and consumer products based thereon | THE PROCTER & GAMBLE COMPANY | 2004-05-06 | — | — | US | disclosed |
| US-20030236180-A1 | Fatty acids, soaps, surfactant systems, and consumer products based thereon | THE PROCTER & GAMBLE COMPANY | 2003-12-25 | — | — | US | disclosed |
| US-6602845-B2 | Fatty acids, soaps, surfactant systems, and consumer products based thereon | THE PROCTER & GAMBLE COMPANY | 2003-08-05 | — | — | US | disclosed |
| US-20030100469-A1 | Fatty acids, soaps, surfactant systems, and consumer products based thereon | CONNOR DANIEL STEDMAN (US) | 2003-05-29 | — | — | US | disclosed |
| US-6395701-B1 | MIXTURE | PROCTER & GAMBLE COMPANY, THE | 2002-05-28 | — | — | US | disclosed |
| CN-1283219-A | Fatty acids, soaps, surfactant systems and consumer products based thereon | PROCTER & GAMBLE (US) | 2001-02-07 | — | — | CN | disclosed |
| EP-1025190-A2 | FATTY ACIDS, SOAPS, SURFACTANT SYSTEMS, AND CONSUMER PRODUCTS BASED THEREON | THE PROCTER & GAMBLE COMPANY (US) | 2000-08-09 | — | — | EP | disclosed |
| WO-1999020722-A2 | FATTY ACIDS, SOAPS, SURFACTANT SYSTEMS, AND CONSUMER PRODUCTS BASED THEREON | THE PROCTER & GAMBLE COMPANY (US) | 1999-04-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260091067-A1 | METHODS AND USES OF MICROBIOME COMPOSITIONS, COMPONENTS, OR METABOLITES FOR TREATING INSULIN-ASSOCIATED DISEASES | IAPP, GPR119, FAHD1 | ALDH1A1 1370/4885FFAR4 88/4885FFAR1 166/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.